S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

XPeng Shares Climb After Revenue Beats Guidance

XPeng’s shares rose after its third-quarter revenue and vehicle margin exceeded expectations, but analysts warned that heavy research spending and a changing sales mix could make sustainable profitability difficult to assess.

XPeng Shares Climb After Revenue Beats Guidance

The Hong Kong-listed shares gained 5.0% to HK$38.42, equivalent to US$4.90, early Tuesday. XPeng’s American depositary receipts closed 3.2% higher at $9.67 overnight.

Revenue increased 23% from the previous quarter to 24.3 billion yuan, or $3.65 billion, above the company’s guidance range of 21.7 billion to 23.4 billion yuan. Higher-than-expected average selling prices and a more favorable product mix drove the beat, Deutsche Bank analyst Bin Wang wrote.

Analysts lowered their price targets despite the stronger results. Deutsche Bank cut its target to HK$65.50 from HK$84.00, while Bernstein reduced its target to HK$59.00 from HK$71.00. “The third quarter was better than expected, but visibility on the path to sustainable profitability remains limited,” Bernstein analysts wrote.

They said continued research and development investment, particularly in physical AI and humanoid robots, is likely to weigh on near-term earnings. Bernstein also warned that a larger share of MONA models in XPeng’s sales mix could pressure vehicle and gross margins, while spending on robotics talent and computing capacity ahead of its humanoid robots could add to the strain.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!